All lobbying filings
DENDREON PHARMACEUTICALS, LLC
DENDREON PHARMACEUTICALS, LLC filed a Q2 report for DENDREON PHARMACEUTICALS, LLC on September 9, 2026.
Lobbying for DENDREON PHARMACEUTICALS, LLC
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Sep 9, 2026
Expenses
$59,650
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
1
Lobbying activity
1
Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.